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Abstract 
 
The Department of Health (2006a) assert that Non-Medical Prescribing 
(NMP) has provided patients with faster access to medicines, improved 
access to health services and made better use of health professionals’ 
skills since it’s inception over a decade ago.  NMP operates from statute, 
and is required be underpinned by a robust clinical governance framework.  
This article provides the reader with a summary of the NMP policy and 
legal context to date, attempting throughout to apply the discussion to the 
field of mental health and learning disability.  It then proceeds to 
demonstrate the means by which NMP was clinically governed in an acute 
NHS trust. The aspects of clinical governance to be particularly focused 
upon comprise the auditing of NMP, implementing independent 
prescribing, regulating NMP for children and young people as well as 
producing patient/service user information.  To date mental health and 
learning disability organisations have mostly implemented supplementary 
prescribing only, and have been slow to implement independent 
prescribing compared to general or primary care settings (Bradley et al 
2008).  However given that independent prescribing is now nationally 
implemented (Department of Health 2006b), it is hoped that the sharing of 
practice innovations and lessons learned in one acute NHS trust with 
colleagues in mental health and learning disability, will be timely.  The 
article then concludes by indicating how monitoring and evaluation of the 
clinical governance established thus far is the necessary next step, as well 
as signposting some further governance challenges for NMP. 
 
Keywords: Clinical governance, Non-medical prescribing, Independent 
prescribing for nurses and pharmacists, prescribing for children and young 
people, patient/ service user information 
 
Introduction 
 
This article provides an overview of the means by which non-medical 
prescribing (NMP) was clinically governed in an NHS trust.  The trust 
involved was an acute NHS trust, but the author believes that the clinical 
governance achieved can be applied to any organisation where NMP takes 
place, particularly in mental health and learning disability settings and this 
will be further explained. 
 
The article commences with an explanation of the policy and legislative 
context of NMP, and in doing so seeks to draw out the significant issues for 
mental health and learning disability NMP.  It then proceeds to explain the 
methodology utilised to ensure that NMP was underpinned by a robust 
clinical governance framework.  This explanation includes initial discussion 
related to the auditing of NMP before continuing with strategic and policy 
directions, particularly with respect to nurse and pharmacist independent 
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prescribing.  To conclude further NMP governance priorities will be 
identified. 
 
Background to Non-Medical Prescribing 
 
The NMP initiative first commenced with nurse prescribing.  Humphries 
and Green (2002) noted that as far back as 1980 the Royal College of 
Nursing were advocating that nurses should be allowed to prescribe 
medicines.  However nurse prescribing first achieved Government policy 
status through the Cumberlege report (Department of Health and Social 
Security 1986).  To assist the then Government agenda of increased 
community care (Department of Health 1989a), Cumberlege was asked to 
investigate how the role and responsibilities of ‘neighbourhood nurses’, 
namely district nurses and health visitors, would need to change to 
facilitate this initiative.  Cumberlege reported that these ‘neighbourhood 
nurses’ regularly and independently assessed patients for conditions 
related to their practice and subsequently made treatment decisions.  
However, they then had to request prescriptions for their patients from 
general practitioners (GPs) which resulted in much time wasting for the 
patients, GPs and the district nurses/health visitors’ alike (Luker et al 
1997).  More significantly Otway (2002) notes that these prescriptions, 
often rubber stamped by the GPs, compromised the safety of patients and 
the accountability of the GPs involved, as the prescription decisions were 
undertaken by those not performing the assessment and examination of 
the patient concerned.   
 
Following on from the Cumberlege report, the first Crown Report 
(Department of Health 1989b) supported prescribing by district nurses and 
health visitors from a limited formulary know then as the Nurse Prescribers 
Formulary.  Brew (1999) reflects on how Crown believed patients would 
benefit as a result of the implementation of her report. 
 
To make the necessary legislative changes to The Medicines Act 1968, 
enabling nurses to prescribe prescription only medicines as advocated by 
Crown (Department of Health 1989b), The Medicinal Products: Prescription 
by Nurses etc Act (1992) was enacted following a Private Member's Bill 
that had been commenced the previous year.  Nevertheless, Luker et al 
(1998) notes that it was 1997 before the scheme was implemented 
nationally, following a pilot exercise at eight sites which commenced in 
1994. 
 
To date there are over 34,000 such prescribers registered with the Nursing 
and Midwifery Council (NMC 2007a).  However other groups, who hold a 
specialist practice qualification, have now been given entitlement to 
prescribe from the renamed Community Practitioners Formulary for Nurse 
Prescribers (CPFNP).  These groups comprise community learning 
disability, psychiatric and children nurses as well as school, practice and 
occupational health nurses (NMC 2006a).  The only means of training to 
prescribe from this formulary currently is within the course of preparation 
for these community specialist routes (NMC 2006a). However more 
recently the NMC (2007b) have set standards for educational preparation 
to enable nurses who do not hold such a specialist practice qualification to 
be able to prescribe from the CPFNP.   
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Suitably trained community psychiatric and learning disability nurses are 
eligible to prescribe from the CPFNP.  An example of how this formulary 
might be relevant is for a community mental health nurse to prescribe a 
service user with nicotine replacement therapy if assistance with smoking 
cessation is requested.  Equally a learning disability nurse might find it 
beneficial to prescribe continence or stoma care aids to service users.  
However mental health/learning disability nurses must ensure knowledge 
and competence before prescribing in this way (NMC 2006a). 
 
Following a change of Government, who in turn were pursuing a 
modernisation agenda, the second Crown report (Department of Health 
1999) proposed two types of prescriber.  The first type of prescriber 
proposed was the independent prescriber, envisaged to be responsible for 
assessment, diagnosis and prescribing for patients without reference to 
another health care professional.  Following on from the NHS Plan 
(Department of Health 2000a) which identified new roles for nurses and 
allied health professionals, the Government launched in 2001 the Nurse 
Prescribers’ Extended Formulary.  This formulary was subsequently 
expanded at least twice following its inception (Department of Health 2002 
& Department of Health 2004a).  It allowed suitably trained nurses, 
midwives and health visitors to prescribe from an extended formulary to 
that of the earlier nurse prescribers’ formulary, for a stipulated list of 
conditions aimed at addressing minor illness and injury, health promotion 
and palliative care.   
 
In the field of mental health and learning disability, the National Prescribing 
Centre (NPC) et al (2005) asserted that most mental health and learning 
disability nurses would not be clinically competent to prescribe as extended 
nurse prescribers.  However, they did recognise that some specialist 
services might wish to develop their nursing staff to prescribe from this 
formulary.  An example of this could have been an organisation supporting 
the training of a nurse in substance misuse to be able to prescribe from the 
extended nurse prescribers’ formulary.  Such a nurse could have 
prescribed to injecting drug misuser’s items for minor ailments, again 
ensuring knowledge and competence to do so (NMC 2006a). 
 
Extended nurse prescribing came to an end when nurse, midwife, health 
visitor and pharmacist independent prescribing was announced in 2006 
(Department of Health 2006a).  More recently optometrists have been 
given approval to independently prescribe for conditions of the eye and 
surrounding tissue.  A suitably trained independent prescriber may 
prescribe any licensed medicine and some controlled drugs according to 
their knowledge and competence (Department of Health 2006b).  With 
regards to controlled drugs, the outcome of a consultation is awaited 
regarding the amendment of The Misuse of Drugs Act (1971) to allow full 
controlled drug prescribing by nurse and pharmacist independent 
prescribers (Medicines and Healthcare Products Regulatory Agency et al 
2007).  To date there are 10,750 independent and supplementary nurse 
prescribers (NMC 2007a).  The NPC et al (2005) noted that in mental 
health and learning disability, a census in mid 2004 revealed that 128 were 
undertaking extended independent and supplementary nurse prescribing 
training with 102 already qualified. Interestingly those involved were 
located in only four organisations, with one organisation providing 45% of 
the specified total. Bradley et al (2008) note that in actual fact mental 
health nurses have been slower than other nursing specialties to take on 
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the prescribing role. Locally to date 31 nurse prescribers have been trained 
from mental health, with none in learning disability, out of a total of 369 
students.  There are no further current national figures available for these 
specialities.   
 
Moving on, the other type of prescribing proposed by the second Crown 
Report (Department of Health 1999) was dependent or, as currently 
referred to, supplementary prescribing.  This type of prescribing was 
subsequently launched in 2003 (Department of Health 2003a) as a result 
of section 63 of The Health and Social Care Act (2001) being enacted to 
allow ministers to create new categories of prescriber.  The first group of 
professionals eligible for training for this role were nurses, midwives, health 
visitors and pharmacists.  However in 2005 further classes of health care 
professionals followed namely physiotherapists, podiatrists, optometrists 
and radiographers (Department of Health 2005a).  Supplementary 
prescribing takes place following an initial assessment and diagnosis of a 
patient’s condition by a doctor. A clinical management plan (CMP) is then 
drawn up for the patient. This plan, agreed by the patient, supplementary 
prescriber and doctor, includes a list of medicines (within the 
supplementary prescribers area of knowledge and competence) from 
which the supplementary prescriber is able to prescribe. This type of 
prescriber is able to prescribe any medicine, but this mode of prescribing is 
best suited to patients with long-term conditions (Department of Health 
2005b).   
 
The NPC et al (2005) particularly welcomed this form of prescribing for 
those in mental health and learning disability.  They recognised the value 
in supplementary prescribing in this field as it: 
 
1. Allows service user’s quicker and more effective access to medicines. 
 
2. Increases service user’s choice. 
 
3. Provides service’s more efficiently. 
 
4. Makes better use of the skills and knowledge of practitioners. 
 
They also saw the benefits of mental health/learning disability 
supplementary prescribing in the following sub-specialities: 
 
1. Older peoples in patient and community services. 
 
2. Acute inpatient care. 
 
3. Assertive outreach. 
 
4. Drug and alcohol teams, particularly when relevant controlled drugs 
can be prescribed. 
 
5. Community mental health teams. 
 
Hemingway (2005) reported how those from these specialities were indeed 
undergoing nurse prescribing training.  He also noted other areas not 
promoted by the NPC et al (2005) where nurse prescribers were being put 
forward for training were: 
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1. Crisis/liaison psychiatry services. 
 
2. Forensic and prison services. 
 
3. Child and adolescent services. 
 
To date there are in excess of 900 pharmacist supplementary prescribers.  
However, over 350 of these pharmacists have undergone conversion 
courses to enable them to prescribe as independent prescribers 
(Department of Health 2008a).  The most recent numbers of Allied Health 
Professional supplementary prescribers are 76 physiotherapists, 43 
podiatrists and 12 radiographers (Department of Health 2008a).  However, 
there is unfortunately no evidence of how many such supplementary 
prescribers are operating in the field of mental health and learning 
disability. 
 
In summary there are three means of NMP currently available, namely: 
 
1. The community practitioners formulary for nurse prescribers. 
 
2. Independent prescribing for nurses, midwives, health visitors, 
pharmacists and optometrists. 
 
3. Supplementary prescribing for nurses, midwives, health visitors, 
pharmacists, optometrists, physiotherapists, podiatrists, radiographers. 
 
To ensure non-medical prescribers are acting within legal and professional 
requirements, individuals may only practice as non-medical prescribers 
once they have had their respective prescribing qualification annotated on 
their entry in the professional register.  They must also ensure that they 
prescribe within the limits of their professional knowledge and competence 
as well as the formulary they are qualified to use.   
 
Hopefully, the discussion above has revealed that all these three types of 
NMP are relevant to those practising in the field of mental health and 
learning disability.  The abolition of the extended nurse prescribers’ 
formulary and the creation of independent prescribing for nurses and 
pharmacists particularly presents new opportunities for those in mental 
health/learning disability and their service users.  The Chief Nursing Officer 
(Department of Health 2006c) endorsed this view by asserting that during 
consultation, nurse prescribing: 
 
“was the new role most frequently cited as one that can be of 
particular benefit to service users” (page 46). 
 
She also recommended the implementation of independent prescribing in 
mental health and learning disability settings. 
 
The purpose of this article therefore is to share practice innovations and 
lessons learned from those areas where independent prescribing has been 
longer established.  A particular focus will be upon clinical governance for 
NMP and specifically independent prescribing.  This will hopefully be of 
relevance to both individuals and organisations, as independent 
prescribing is implemented in mental health and learning disability. 
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Clinically Governing Non-Medical Prescribing in an NHS Trust 
 
The Department of Health have produced guidelines for both independent 
(Department of Health 2006b) and supplementary (Department of Health 
2005a) prescribers to follow.  Both these guidance documents require that 
organisations underpin NMP with a robust clinical governance framework.  
Clinical governance for NMP is also endorsed by the National Prescribing 
Centre (NPC) et al (2005).  Scally and Donaldson (1998) assert that 
clinical governance is   
 
‘A framework through which NHS organisations are accountable for 
continuously improving the quality of their services and safeguarding high 
standards of care by creating an environment in which excellence in 
clinical care will flourish.’ (Accessed online) 
Clinical governance is an umbrella term incorporating the following 
components: 
• Patient, public and carer involvement.  
• Strategic capacity. 
• Risk management. 
• Staff management and performance.  
• Education, training and continuous professional development. 
• Clinical effectiveness. 
• Information management.  
• Communication. 
• Leadership. 
• Team working. 
 
The NPC et al (2005) recommended a similar clinical governance structure 
to organisations implementing nurse prescribing in mental health and 
learning disability. 
 
This article shares the experience of clinically governing NMP in an NHS 
trust.  Scally and Donaldson (1998) umbrella terms, easily applicable to 
NMP, were pertinent to that process as will be further explained.   
 
Audit 
 
Clinical governance of NMP had been in place in the Trust since the 
inception of extended independent nurse prescribing in 2002 (Department 
of Health 2002) and the subsequent launch of supplementary prescribing 
(Department of Health 2003a).  Following a meeting between the Director 
of Pharmacy, the Trust and University NMP Leads and the non-medical 
prescribers within the Trust in July 2006, the initial course of action was to 
undertake an audit of non-medical prescribers within the organisation.  
This audit had a number of objectives: 
 
1. To determine those prescribing within the Trust and the scope of their 
current prescribing. 
 
2. To examine non – medical prescribers perceptions of clinical 
governance arrangements within the Trust with regards to NMP. 
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3. To identify the continuing professional development (CPD) thus far 
undertaken by non-medical prescribers and their future needs. 
 
4. To determine non-medical prescribers views on the implications of 
independent prescribing to their practice following the recent 
announcement by the Department of Health (Department of Health 
2006a). 
 
Undertaking this audit was also thought to be a useful exercise in providing 
a snapshot on current practice in this area, which in turn could then inform 
future development of the trust’s NMP strategy and policy.  Moreover 
undertaking this audit also enabled the Trust to address a West Yorkshire 
Workforce Development Confederation (WYWDC now Yorkshire and 
Humber Strategic Health Authority) (2006) clinical governance priority 
which requires that: 
 
“Feedback from non-medical prescribers provides a source of 
information for quality improvement within the trust”. (Page 1) 
 
Finally the audit, and indeed review of clinical governance for NMP, was 
deemed to be timely considering the recent announcement of independent 
prescribing for nurses, midwives and pharmacists (Department of Health 
2006a) as well as the expansion of supplementary prescribing to allied 
health professionals (Department of Health 2005a).  
 
The audit used a survey containing open and closed questions which were 
shaped by available benchmarks, such as the: 
 
• Department of Health (2005a) Supplementary prescribing by nurses, 
pharmacists, chiropodists/podiatrists, physiotherapists and 
radiographers within the NHS in England: A guide for implementation - 
revised edition. 
 
• Department of Health (2006b) Improving patients’ access to medicines: 
A guide to implementing nurse and pharmacist independent prescribing 
within the NHS in England. 
 
• NMC (2006a) Standards of Proficiency for Nurse and Midwife 
Prescribers. 
 
• WYWDC (2006) clinical governance priorities for NMP. 
 
• The data was analysed by Excel with the open responses undergoing 
thematic analysis.   
 
Audit Findings 
 
The NMP audit was distributed in September 2006 to 22 non-medical 
prescribers, who were all nurses only at that time.  Responses were 
received from 14 nurse prescribers.  Some of the findings bore a 
resemblance to those of Department of Health (2005c), particularly in 
terms of prescribing rates, confidence and CPD.  The respondent’s were 
made up of 7 clinical nurse specialists with the remaining respondents 
occupying other nursing roles such as specialist sister’s and staff nurses.  
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Their length of service in their current role ranged from 3 to 14 years with 
the average length of service being 7.6 years.  Hemingway (2005) believes 
that length of service in excess of 6 years prior to commencing prescribing 
training could be reassuring, as it suggests experiential learning and 
competence.  However, he also notes that it could suggest an ageing 
workforce which has implications for NMP succession planning. 
 
The year of qualification as nurse prescriber’s was 2003 for 5 respondents, 
2004 for 2 respondents, 2005 for a further 2 respondents with the 
remaining 5 qualifying in 2006.   
 
Turning to support received from their medical mentors during and since 
training, 10 respondents reported receiving excellent support from their 
medical mentors.  Indeed 9 out of these 10 respondents reported that they 
were continuing to receive and value such support following qualification.  
The tenth respondent reported that she had left the organisation in which 
she undertook prescribing training so therefore she had no further contact 
with her former medical mentor.   
 
Of the 14 respondents, 9 were prescribing between 1 – 20 items per week 
with the average being 12 items per week.  The respondents reported 
prescribing a range of medicines as either extended independent and/or 
supplementary nurse prescribers.  There were 5 respondents who 
prescribed as both extended independent and supplementary nurse 
prescribers with the remaining 4 only using supplementary prescribing 
arrangements.  Some individuals proceeded to identify the medicines they 
wish to prescribe as independent prescribers.   
 
In terms of confidence in their prescribing, 6 of those prescribing reported 
feeling very confident in this role with the remaining 3 feeling fairly 
confident.  The responses implied a correlation between length of 
prescribing practice and confidence, as one prescriber who commenced 
prescribing in the audit year reported feeling fairly confident in their new 
role, whilst most of those who have been qualified in excess of a year 
reported feeling very confident.  It is worth noting that of the five 
respondents feeling very confident as a prescriber, four respondents still 
believe they were supported by their mentor.  Both of those who report to 
feeling fairly confident were also receiving medical mentor support.  This 
underlines how pivotal medical mentor support is to non-medical 
prescribers during and following their prescribing training (NPC 2005).  
Hemingway (2005) agrees noting that this echoes research undertaken in 
the United States where support from medical staff following qualification 
was a real determinant in those mental health nurse prescribers who went 
on to prescribe post qualification (Howard and Greiner, 1997; Kaas et al, 
1998; Talley and Richens, 2001). 
 
The following table (Table 1) denotes the respondent’s knowledge of 
clinical governance arrangements for NMP in the trust.  The key issues 
identified were the respondent’s perceptions of the lack of: 
 
• Patient information related to NMP; (to be explored later in the context 
of mental health/learning disability service users). 
 
• Risk management processes to review incidents involving NMP. 
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• Cross boundary prescribing agreements between organisations.  
Bradley et al (2008) noted this as a issue for mental health/learning 
disability non-medical prescribers, a concern highlighted locally by 
Clibbens et al (2008). 
 
Table 1 – Respondents Knowledge of Clinical Governance 
Arrangements for NMP 
 
 Yes No Don’t 
know/ 
missing 
data 
A database of all the non-medical 
prescribers employed by the Trust 
 
9 2 3 
An updated job description/person 
specification to include NMP activity 
 
7 2 5 
NMP strategy/polices/procedures 
 
11 1 2 
Access to internet/Intranet 
 
14   
A current British National Formulary 
 
 
13 1  
Clinical governance and/or audit 
support for NMP 
 
2 3 9 
Access to a pharmacist 
 
13  1 
Patient information outlining NMP  4 10 
 
Guidance on contacts between trust 
staff and representatives of the 
pharmaceutical Industry 
 
9  5 
Cross boundary prescribing 
agreements between organisations 
 
 3 11 
Information on medicine alerts and 
other relevant updates. 
 
12  2 
Risk management processes are in 
place to review incidents involving 
NMP 
 
6 1 7 
Support networks with other non-
medical prescribers. 
 
8 2 4 
 
The next table (Table 2) indicates the respondent’s perceived barriers to 
NMP.  The key barriers identified by respondents were: 
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• independent prescribing not permitted in the trust. 
 
• time available to attend continuing professional development (CPD). 
 
Again, Clibbens et al (2008) notes similar views from non-medical 
prescribers in mental health and learning disability settings locally, while 
the Chief Nursing Officer (Department of Health 2006c) observes the same 
issues nationally. 
 
Table 2  - Respondents Perceived Barriers to NMP 
 
 Yes No Don’t know/ 
Missing data 
Lack of job description/personal 
specification to cover prescribing role 
 
4 7 3 
Prescribing budget constraint 
 
 7 7 
Independent prescribing not permitted 
in the trust 
 
6 3 5 
Time available to write prescriptions 
 
 13 1 
Time available to access patients 
notes  
 
1 12 1 
Time available to record prescriptions 
 
1 8 5 
Time available to attend continuing 
professional development 
 
6 5 3 
 
Despite one of the perceived barriers to NMP being the time available for 
CPD, the respondents were clearly engaging in a range of post prescribing 
qualification learning activities.  The CPD being accessed included medical 
mentor led sessions, the trust NMP support network, NPC, industry and 
university updates as well as reference to the internet and journals.  The 
CPD needs identified included further NPC, university and industry 
updates, trust non-medical prescribers meetings and clinical supervision.  
Finally taught sessions on the law, antimicrobials, drug interactions, 
adverse drug reactions, and new products were also sought.   
 
Both the CPD activity accessed and required matches the range of CPD 
opportunities identified by Bramley (2006) and Clibbens et al (2008).  One 
omission in terms of how respondents either accessed CPD activity or 
identified future needs was the use of NPC competency frameworks (NPC 
2001, 2003, 2004 & 2006).  This too was noted by Clibbens et al (2008).  
Linked to CPD, 3 respondents reported receiving clinical supervision 
related to their prescribing role.  Unfortunately however the survey 
instrument did not identify who was providing clinical supervision and how 
often such supervision took place.  Furthermore no respondents reported 
receiving appraisal related to their prescribing role, as required by the NMC 
(2006a).  Neither did respondents report undertaking audit related to their 
prescribing role. 
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Audit Recommendations  
 
From the findings of the survey the following recommendations were 
presented to the Trust Medicines Management Committee. 
 
1. Implement independent prescribing within the Trust for suitably 
qualified nurses and pharmacists.  However, before individuals 
prescribe independently a list of medicines and conditions must be 
approved by a lead clinician and the Trust Medicines Management 
Committee. 
 
2. Revise Trust NMP strategy and policy in the light of related Department 
of Health policy change and statutory body standards.   
 
3. In revising trust NMP strategy and policy, address WYWDC clinical 
governance priorities. 
 
4. Produce patient information for NMP. 
 
5. Repeat the audit in 2007-8 following the implementation of independent 
nurse/pharmacist prescribing and supplementary prescribing for allied 
health professionals. 
 
Addressing these points in the Trust will now form the remainder of the 
discussion within this article. 
 
Strategic Direction  
 
The Department of Health (2005a & Department of Health 2006b) 
guidance requires that organisations develop a strategic plan for use with 
NMP.  The Department of Health envisage that producing and approving 
such a plan would typically involve senior managers, clinicians (doctors, 
nurses, pharmacists and specified allied health professionals eligible to 
train as non-medical prescribers), and the drug and therapeutic committee 
(or equivalent).  Within this Trust, the strategy was produced by the NMP 
network, led by the Trust NMP lead.  It was then approved by the 
Medicines Management Committee and the Clinical Management 
Committee.   
 
The Department of Health recommends that content for a NMP strategic 
plan addresses: 
 
1. The benefits to patients of NMP. 
 
2. An initial range of clinical areas where patients could benefit. 
 
3. A way to support and sustain the transition of staff to extended roles 
and the services they currently provide. 
 
4. A communications plan aimed at informing both patients and all clinical 
and managerial staff. 
 
5. Timescales for implementation. 
 
6. The identification of a NMP lead. 
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Likewise this Department of Health guidance requires that NMP operates 
within a robust clinical governance framework.    
 
Turning to each of the first four of these above-mentioned points 
particularly, the Department of Health assert that NMP should provide the 
following benefits to patients: 
 
• Improved patient care without compromising patient safety. 
 
• Easier and quicker access for patients to the medicines they need. 
 
• Increased patient choice in accessing medicines. 
 
• Better use of the skills of health professionals. 
 
These strategic aims are shared with those identified for use in mental 
health/learning disability by the NPC et al (2005) and discussed above.  
For the Trust, NMP assisted with the provision of more patient-centred 
services.  It also enabled rapid access to medicines with the use of less 
health care professionals in the patient journey.  This then had the 
potential to enhance the patient experience, connecting to the intentions of 
the current NHS review (Department of Health 2007ab). 
 
The Department of Health indicates that NMP contributes to the provision 
of flexible care delivery.  Following the reconfiguration of Trust services, 
priority clinical areas for NMP emerged.  These included: 
 
• Assessment for acute patients. 
 
• Children’s assessment. 
 
• Pre-operative assessment. 
 
• The management of long term conditions. 
 
These identified areas translate to similar priority areas for NMP in mental 
health and learning disability.  Such areas have been identified by the NPC 
et al (2005) and discussed earlier.  However to recapitulate, assessment of 
the service user group across the lifespan is a key component of mental 
health and learning disability services, endorsed by current Government 
policy (Department of Health 2008b). 
 
The Trust reconfiguration also relied on changes in practice which both 
prevented hospital admission and reduced lengths of stay.  Therefore the 
continued selection of clinical areas for NMP sought to enhance the 
patient’s journey from admission to discharge which will assist the 
achievement of the 18 week target within the Trust (Department of Health 
2006d). 
 
To ensure patient safety the Trust prioritised areas for NMP indicated by 
over reliance on patient group directions (PGDs) and/or the incidence of 
medication errors.  Incrementally, the Trust is seeking to reduce it’s 
provision of medicines using PGDs in line with Department of Health 
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(2000b) guidance.  In mental health and learning disability, NMP may 
assist in the recommendations from the National Patient Safety Agency 
(NPSA) (2006) with respect to medication safety for this particular client 
group. 
 
To maximise the use of skilled health professionals, the Trust encourages 
those employed in autonomous and specialised roles to become non-
medical prescribers.  For nurse prescribers, this dovetails neatly with the 
ambitions laid out for advanced practice in ‘Modernising Nursing Careers’ 
(Department of Health 2007b). 
 
Finally, communication for NMP within the Trust was designed to operate 
at three levels: 
 
1. The first level was with the patient.  To comply with statutory body and 
Department of Health standards non-medical prescribers must ensure 
that patients are aware that they are being treated by a non-medical 
prescriber and of the scope and limits of their prescribing.  It will be the 
responsibility of the individual non-medical prescriber to provide this 
information to patients accordingly.  However the Trust produced and 
approved written information relating to assist with informed consent.  
More discussion will ensue on this point later in this article. 
 
2. The next level was with the non-medical prescriber.  The non-medical 
prescriber is responsible for communicating their prescribing role within 
their particular service.  
 
3. The final level rests with the Trust NMP lead:  The NMP lead provides 
strategic communication related to this initiative.  This involves 
promoting NMP where appropriate, as well as acting as a conduit for 
communication on this initiative both within and without the Trust.   The 
network of non-medical prescribers is also led by the Trust NMP lead. 
 
Policy 
 
The key instrument of NMP clinical governance in the organisation is the 
Trust policy.  It takes reference from the first domain of the Healthcare 
Commission Standards (Department of Health 2006e) addressing safety.  
Core standards 4d requires that healthcare organizations keep patients, 
staff and visitors safe by having systems to ensure that medicines are 
handled safely and securely.  Likewise it connects to the National Health 
Service Litigation Authority (NHSLA) Risk Management Standards (2007).  
In particular it related to standard 4 dealing with clinical care, and criterion 
6 addressing medicines management.  Similar standards operate in the 
field of mental health and learning disability (Healthcare Commission 
2007). 
 
The policy document sets a framework to encompass NMP, from the 
selection of individuals for training through to their practice on qualification.  
It is governed by the standards set for NMP by the Department of Health 
(2005a & Department of Health 2006b), but, furthermore, embeds the 
requirements of the regulators for those who can practice as non-medical 
prescribers (National Prescribing Centre & Department of Health 2004, 
Nursing and Midwifery Council 2006, and Royal Pharmaceutical Society of 
Great Britain 2006).  The following discussion will seek to highlight some 
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key elements of the policy which either linked to national NMP agendas or 
the audit of NMP undertaken in the Trust.  These elements include: 
 
• Implementing and governing independent prescribing for nurses and 
pharmacists. 
 
• Prescribing for children and young people. 
 
• Patient information. 
 
Implementing Independent Prescribing for Nurses and 
Pharmacists 
 
As revealed above, clinically governing NMP in the Trust was timely for a 
number of reasons, but a key driver was the Department of Health (2006b) 
implementation of independent nurse and pharmacist prescribing.  
Furthermore, the audit described earlier, identified that current nurse 
prescribers were keen to be able to prescribe independently any licensed 
medicine according to their knowledge and competence.  Therefore one of 
the first priorities following the audit, was to develop a means to permit 
independent prescribing, which was underpinned by robust clinical 
governance arrangements.   
 
The method adopted was based on work published by the National 
Electronic Library for Medicines (NELM) (2006).  A proforma was 
developed which captures the intention to practice for non-medical 
prescribers.  The information required on the proforma is contained within 
three main sections, with additional biographical details included. 
 
The first proforma section involves the non-medical prescriber identifying 
the disease area to be prescribed for, accompanied by their evidence of 
competence in this area and related CPD.  This section concludes by 
requiring the non-medical prescriber to stipulate the evidence underpinning 
this area of therapeutics. Such evidence may include NICE guidelines, 
National Service Frameworks or Trust protocols.   
 
The second section links to issues identified in the original NMP audit.  
Within this section, non-medical prescribers must detail both their activity 
and intentions in NMP appraisal, clinical supervision, audit and CPD.   
 
The final section necessitates signature by the non-medical prescriber’s 
manager and their lead medical clinician before presentation for approval 
at the Trust Medicines Management Committee.  Following approval, 
independent prescribing may proceed but should the non-medical 
prescriber seek to add additional items to their prescribing, an ‘additions 
proforma’ must first be completed and approved.   
 
This arrangement could assist the implementation of clinically governed 
independent prescribing in mental health and learning disability settings.  
So far non-medical prescribers in this arena, through mostly 
supplementary prescribing arrangements, have operated in prescribing 
partnerships with doctors.  Such prescribing partnerships may have been 
more longstanding than those of their general or primary care counterparts.  
Indeed Clibbens et al (2008) noted an individual who had been a 
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supplementary prescriber in mental health for three years.  Therefore using 
this proforma, doctors are well placed to assess the competence and 
therapeutic intentions of those supplementary mental health/learning 
disability nurse prescribers who now wish to expand into independent 
prescribing.  Equally the therapeutic knowledge, CPD and audit activity 
underlined by Clibbens et al (2008) are all required within the proforma.   
 
NMP for Children and Young People 
 
The second NMP clinical governance priority addressed the NMC (2007c) 
requirements related to nurse prescribing for children and young people.  
First the trust policy requires that in terms of all NMP for children and 
young people, and not just nurse prescribing, a consultant paediatrician 
only is allowed to provide mentorship to those undergoing training.  
Furthermore, the proforma described above assisted with the 
implementation of this requirement.  Thus the Trust determined that a 
consultant paediatrician is the only doctor that can confirm the prescribing 
intentions of either an independent prescriber, or the clinical management 
plan utilised in supplementary prescribing with respect to children and 
young people.   
 
Hemingway (2005) indicates the usefulness of NMP in child and 
adolescent mental health services.  As these services address The 
Children’s Plan (Department for Children, Schools and Families 2007) and 
standard 9 of the National Service Framework for Children, Young People 
and Maternity Services (Department of Health 2004b), NMP will inevitably 
play a part and this model of governance should fit those services.  As 
such, a clinician, who specialises in child and adolescent psychiatry or 
learning disability, could verify diagnostic and therapeutic competence for a 
non-medical prescriber wishing to prescribe independently for this service 
user group. 
  
Patient Information 
  
Finally, the last clinical governance priority for discussion involved the 
production of a patient information leaflet for NMP.  This leaflet is a vital 
means of ensuring patient consent to NMP.  With regard to supplementary 
prescribing, a clinical management plan is not lawful without patient 
consent (Department of Health 2005a).  For both independent and 
supplementary prescribing, patients need to provide consent to having 
medicines provided by a non-medical rather than a medical prescriber 
specifically (Department of Health 2005a & Department of Health 2006b), 
in addition to providing consent to examination and treatment in general 
(Department of Health 2001).   
 
In mental health and learning disability, information for service users with 
respect to NMP is timely given that the Government has produced recent 
guidance for this group on medicines management as well as their health 
care professionals (Department of Health 2008c).  Therefore, any service 
user NMP information needs to be developed to complement this 
medicines management guidance.   
 
The leaflet developed in the acute NHS trust was designed using the 
Department of Health (2003b) toolkit for producing patient information but 
took reference from NMC guidance (2006b).  Following proof reading by 
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patient groups, the leaflet was amended to remove the term controlled 
drug and clarify the meaning of the term ‘optometrist’.  This served as a 
reminder that medical jargon does not easily translate into universal 
understanding, thus concurring with the opinions of Wolff (2008).  The 
recent implementation of this leaflet requires that evaluation of its 
usefulness with patients’ is the necessary next step. 
 
Conclusion 
 
In conclusion, this article has demonstrated some of the methodology for 
achieving clinical governance for NMP in an organisation, and as such 
could be applied to any setting where this initiative takes place.  Presented 
in this article is a means by which independent nurse and pharmacist 
prescribing can be clinically governed, which is timely as NMP colleagues 
in mental health and learning disability consider developing this within their 
organisations.  However, a key next step in ensuring the clinical 
governance arrangements proposed continues to provide a robust 
framework, is the monitoring and evaluation of the systems and processes 
developed.  Such monitoring and evaluation needs to focus particularly on: 
 
1. The effectiveness of the systems developed for independent 
prescribing and NMP for children and young people.  This could be 
achieved by undertaking further audit of non-medical prescribers. 
 
2. The usefulness of any patient/service user information leaflet. 
 
3. Patient/service user satisfaction with NMP. 
 
Following implementation of the NMC (2006a) Standards of Proficiency, a 
further key area for organisation’s to address is the determination of 
diagnostic and therapeutic competence prior to nurse’s being put forward 
for prescribing training.  A solution could be to amend the independent 
proforma so that such determination of competence is undertaken prior to 
individual’s applying for NMP training.   
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